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Abstract
Background: The natural plant polyphenol resveratrol present in some foods including grapes,
wine, and peanuts, has been implicated in the inhibition, delay, and reversion of cellular events
associated with heart diseases and tumorigenesis. Recent work has suggested that the cancer
chemoprotective effect of the compound is primarily linked to its ability to induce cell division cycle
arrest and apoptosis, the latter possibly through the activation of pro-apoptotic proteins such as
Bax.
Methods: The expression, subcellular localization, and importance of Bax for resveratrol-
provoked apoptosis were assessed in human HCT116 colon carcinoma cells and derivatives with
both bax alleles inactivated.
Results: Low to moderate concentrations of resveratrol induced co-localization of cellular Bax
protein with mitochondria, collapse of the mitochondrial membrane potential, activation of
caspases 3 and 9, and finally, apoptosis. In the absence of Bax, membrane potential collapse was
delayed, and apoptosis was reduced but not absent. Resveratrol inhibited the formation of colonies
by both HCT116 and HCT116 bax -/- cells.
Conclusion: Resveratrol at physiological doses can induce a Bax-mediated and a Bax-independent
mitochondrial apoptosis. Both can limit the ability of the cells to form colonies.
Background
Cancers claim at least six million lifes per annum world-
wide, and the common and frequently therapy-resistant
colon cancers are among the most notorious. Accordingly,
natural food constituents capable of inhibiting, delaying
or reversing events associated with tumor initiation, pro-
motion, and progression have attracted much attention.
The pharmacologically active trans form of the polyphe-
nolic, antifungal phytoalexin resveratrol (3,5,4'-trihy-
droxy-trans-stilbene) is produced by more than 70 plant
species and is reaching particularly high levels in grapes,
peanuts and wine [1]. A large number of publications in
recent years has shown that physiological quantities of
resveratrol can modulate multiple cellular pathways rele-
vant for tumorigenesis, among them phase II drug metab-
olizing, cyclooxygenase, nitric oxide, DNA-synthesis, and
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and cell cycle pathways [2]. The consensus of the many in
vitro- and a limited number of in vivo-studies seems to be
that micromolar quantities of the compound can not only
counteract tumor initiation through anti-oxidant activi-
ties and the inhibition of enzymatic carcinogen conver-
sion [2–4], or counteract tumor promotion through
cyclooxygenase and hydroperoxidase inhibition [5,6], but
can affect tumor cell proliferation and survival through
the inhibition of cell cycle, stimulation of differentiation,
and induction of apoptosis [2–4]. The latter effects may be
of particular relevance for the anti-tumorigenic activity of
resveratrol [2], not least because the cell cycle/cell death
machinery is specifically altered in many tumor cells and
the targeting of this machinery by resveratrol opens up the
possibility to specifically affect tumor cells and spare nor-
mal proliferating tissue. The compound indeed seems to
possess some specificity for tumor cells [7].
At the level of individual proliferating cells, resveratrol ap-
pears to act primarily though the inhibition of the cell cy-
cle [8–14]. Although apoptosis may be provoked in
normal, non-transformed proliferating cells exposed to
high resveratrol concentrations [11], a temporary, reversi-
ble cell cycle arrest in G1 and G2 phase has been reported
to result at low to moderate concentrations from activa-
tion of the p53 tumor suppressor and, subsequently, from
the activation of the p21Cip1 inhibitor of cyclin-depend-
ent kinases [14,15]. In tumor cells however, p53 function
is frequently lost, and consequently, cells usually arrest in
S-phase instead of G1 or G2, probably due to the inhibi-
tion of DNA synthesis by resveratrol [16,17]. Although
this cell cycle arrest is also reversible, cells with altered cell
cycle checkpoints can be more prone to apoptotic death
[14,15,18].
The precise mechanisms through which resveratrol induc-
es apoptosis are unknown. Together, the available data
point to the existence of several apoptotic pathways that
can be triggered by the compound, and to the existence of
survival pathways that can be inhibited by it. For example,
resveratrol has been documented to be able to induce ap-
optosis through the activation of p53 [19], but also
through other mechanisms in wild-type p53-deficient tu-
mor cells [8]. Furthermore, the compound has been
shown to inhibit the activation of NFkB transcription fac-
tor which serves as a survival factor in some cell types
[20,21].
Apoptosis following resveratrol treatment has been re-
ported to be mediated, in dependence on cell type,
through the death receptor [22] and mitochondrial path-
ways [14,23]. Recent findings make the involvement of
the death receptor pathway questionable though [24,25].
For instance, dominant-negative inhibition of this path-
way failed to block apoptosis induction by a resveratrol
analog [24]. The pro-apoptotic Bax protein is one of the
major players in the mitochondrion form of apoptosis
[26], and mitochondria-mediated cell death induced by
resveratrol may involve stimulation of the expression of
the bax gene by p53 or other transcription factors
[10,14,27,28]. However, mitochondria-mediated cell
death may also involve down-modulation of Bax-antago-
nists such as Bcl-XL or Bcl-2 [29], or the translocation of
Bax from the cytosol to mitochondria ([30] and discus-
sion therein). Since Bax was activated moderately or weak-
ly under resveratrol in some cell types [10,14,27], or was
activated only at high drug concentrations although apop-
tosis was observed at low concentrations as well [14], the
present work was designed to address the role of Bax in co-
lon tumor cell apoptosis more directly by studying the ef-
fect of the drug on the human HCT116 colon carcinoma
cell line and a derivative in which both bax alleles were
disrupted by spontaneous frameshift mutation and target-
ed homologous recombination [31].
Methods
Reagents and cell culture
Resveratrol was purchased from Alexis (San Diego, CA).
JC-1 and MitoTracker Red were obtained from Molecular
Probes (Eugene, OR). ADR, 5-FU, and PI were provided by
Sigma (St. Louis, MO). Rabbit polyclonal antibodies Bax
N-20, Bcl-XL S-18, Bcl-2 N-19, and cytochrome b were
from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
polyclonal caspase 3 antibody and mouse monoclonal
caspase 8 and Bax 6A7 antibodies were purchased from
Transduction Laboratories/Pharmingen (San Diego, CA).
The rabbit polyclonal caspase 9 antibody detecting a 36
kDa cleavage product of pro-caspase 9 was from BioVision
(Mountain View, CA). Peroxidase-conjugated anti-rabbit
and anti-mouse secondary antibodies, the -actin and
FITC-labeled anti-mouse monoclonal antibodies, and a
liquid alkaline phosphatase detection kit were from Sig-
ma. Stock solutions of resveratrol and Mitotracker Red
were prepared in DMSO; JC-1 was dissolved in methanol;
ADR, 5-FU, and PI stocks were prepared in water. The
HCT116 cells and derivatives were cultured as monolayers
at 37C in a humidified 7% CO2 atmosphere in McCoy's
5A medium supplemented with 10% FCS. HT29 cells
were maintained in DMEM plus 10% FCS.
Immunoblotting and subcellular fractionation
Cells were seeded in 10 cm dishes to approx. 50% conflu-
ence at 24 h before resveratrol treatment. Protein extracts
were prepared by lysing the cultures in 150 l of lysis buff-
er heated to 90C and containing 50 mM Tris-HCl (pH
6.8), 100 mM DTT, 2% SDS, and 20% glycerol. Samples
containing 15 or 30 g of total cellular protein were sub-
jected to SDS-PAGE and transferred to a nitrocellulose
membrane (Immobilon-P, Millipore, Bedford, MA).Page 2 of 9
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ies directed against -actin (1:5,000), Bax or cytochrome
b (1:500), and Bcl-XL, Bcl-2, or one of the caspases (1:200,
respectively). For signal detection, the secondary anti-
mouse antibody was used at a dilution of 1:5,000, and the
secondary anti-rabbit antibody at 1:1,000. For the prepa-
ration of subcellular fractions, at least 107 cells were
scraped off the dishes, washed with PBS, suspended in 0.5
ml fractionation buffer (20 mM HEPES pH 7.5, 10 mM
KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM
DTT, 0.1 mM PMSF, and 10 g/ml each of leupeptin,
aprotinin, and pepstatin A; supplemented with 250 mM
sucrose), and homogenized by 10 strokes with a Dounce
homogenizer. Nuclei and residual unlysed cells were pel-
leted at 750 g for 5 min (4C). The high membrane (HM)
fraction containing the mitochondria was harvested by
centrifugation at 10,000 g for 15 min (4C), and the su-
pernatant was collected as the cytoplasmic fraction. The
quality of all fractions was routinely tested by Western
blotting with antibodies specific for nuclear proteins (an-
ti-PCNA, p53, Rb), cytoplasmic proteins (anti-eIF4A, -tu-
bulin), and mitochondrial proteins (anti-cytochrome
oxidase, cytochrome b, c).
Immunofluorescence and membrane potential changes
To stain mitochondria (MT), cells were incubated with
250 nM Mitotracker Red in pre-warmed full medium for
30 min at 37C and washed twice with full medium. For
immunofluorescence, cells were washed in pre-warmed
full medium and fixed for 15 min at 37C in full medium
containing 3.7% formaldehyde. The cells were then
washed with PBS and permeabilized with 0.2% Triton X-
100 in PBS for 5 min at room temperature. After repeated
washes with PBS, cells were incubated with the primary
anti-Bax antibodies (1:100) or appropriate controls for 1
h, washed twice with PBS, exposed to the secondary FITC-
labeled anti-rabbit antibody (1:50), and finally examined
with a Leitz fluorescence microscope. For membrane po-
tential (m) analysis, 2  105 cells were trypsinized,
washed in pre-warmed medium, resuspended in McCoy's
5A medium supplemented with 0.2% FCS and JC-1 at 10
g/ml, and incubated for 30 min at 37C. The MT mem-
brane potential is reflected by the quotient of red vs. green
fluorescence measured by FACscanning; observation
wavelengths were 530 nm for the green fluorescence and
585 nm for the red fluorescence.
FACS analysis and colony formation assay
Cells were seeded in 6-well dishes to approx. 20 % conflu-
ency 24 h prior to resveratrol treatment. Asynchronously
growing cultures were harvested by trypsinization, com-
bined with the cells floating in the medium, washed with
PBS, resuspended in 100 l of 0.9% NaCl, squeezed
through a 23.5 gauge needle into 0.9 ml of methanol and
fixed for 30 min at -20C. Cells were then repeatedly
washed with PBS, resuspended in PBS supplemented with
RNase A (25 g/ml) at approx. 106 cells/ml, and stained
with PI (25 g/ml) for at least 1.5 h at 4C in the dark.
DNA fluorescence was measured with a Becton Dickinson
FACScan (Bedford, MA); the Cell Quest software (Becton)
was employed for data acquisition and analysis. Cells
with a less-than-2n DNA content were apoptotic. For col-
ony formation assays, initially 1.5, 3, and 4.5  103 live
cells, counted with a CASY cell counter, were seeded in 25
cm2 tissue culture flasks and incubated for approx. 10
days until colonies formed. Since untreated bax -/- cul-
tures were able to produce approx. 5 more colonies than
the parental HCT116 cells, the numbers of seeded live
cells were adjusted to produce equal colony numbers for
the drug treatment experiments. Colonies were fixed with
0.25 % glutaraldehyde and stained with crystal violet.
Results
Human colorectal adenocarcinoma HCT116 is a poorly
differentiated, growth factor-insensitive cell line deficient
for hMLH1, a homologue of the bacterial Mut L protein
and crucial component of DNA mismatch repair. The
present study has made use primarily of HCT116 and the
isogenic cell lines HCT116 p53-/- and HCT116 bax-/- de-
rived from the parental line by targeted disruption of the
p53 alleles or – in the case of the bax alleles – by a combi-
nation of spontaneous frameshift mutation and targeted
disruption [31,32]. HCT116 cells are responsive to a vari-
ety of stresses including DNA damage and spindle disrup-
tion, in part owing to the integrity of the wild-type p53
tumor suppressor pathway. For this reason, and since de-
regulated colon epithelial cells are the supposedly primary
targets of natural cancer chemopreventive food constitu-
ents, this cell line has been frequently employed for the
study of the molecular mechanisms of drug action. We
have recently reported that the polyphenol resveratrol
present in some foods can increase the steady-state levels
of pro-apoptotic Bax protein and induce a mitochondria-
mediated apoptosis in HCT116 cells independently of
p53 [14]. However, although Bax overproduction in re-
sponse to 100 M resveratrol was weak, and at lower drug
doses (< 40 M), undetectable (Figure 1A), doses of 10 to
20 M were able to provoke significant apoptotic cell
death (typically 9 to 25 % within 48 h vs. 5 % in mock-
treated cultures, Figure 1B). We therefore asked what role,
if any, Bax might have in the resveratrol-induced apopto-
sis of HCT116 cells.
Previous work has documented that subtle shifts in the ex-
pression levels of Bax-interacting anti-apoptotic members
of the Bcl-2 family of proteins can influence cell survival
even when Bax levels are unchanged [29]. We failed to de-
tect changes of the steady-state levels of anti-apoptotic
Bcl-XL in response to resveratrol (Figure 1A), and Bcl-2
was not detectably produced in HCT116 cells, indicatingPage 3 of 9
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via alterations in the Bax/Bcl-XL ratio. Recent work has
furthermore shown that Bax levels do not always increase
following apoptotic stimuli but that, instead, the occlud-
ed N-terminus of Bax may become exposed and the pro-
tein may then co-localize with the mitochondria ([30]
and discussion therein). When mock-treated formalde-
hyde-fixed HCT116 cells, p53-deficient HCT116 p53 -/-
cells, or HCT116 bax -/- cells were stained with anti-Bax-
antibody 6A7 (Pharmingen/Transduction Labs) or an an-
tibody raised against the conformation-sensitive N-termi-
nus of Bax (N20, amino acids 11 to 30, Santa Cruz), both
antibodies recognized a protein in the bax-positive
HCT116 cells and produced a diffuse immunofluores-
cence signal (see Figure 2, mock-treated cultures), whereas
no fluorescence was produced in the bax -/- or isotype
controls (not shown), indicating that staining was specific
and that the N-terminal epitope of at least a fraction of the
Bax molecules was exposed in untreated HCT116 cells af-
ter standard fixation.
Treatment of the cells with 100 M resveratrol for 24 h re-
sulted in the redistribution of Bax, regardless of p53-sta-
tus, producing a distinctive, punctuate staining pattern in
the cytosol with perinuclear concentration, resembling
the pattern produced by the mitochondria-specific Mi-
totracker Red dye (Figure 2A). Confocal imaging con-
firmed that a fraction of the Bax immunofluorescence
merged with the mitochondrial staining; however, a pro-
portion of Bax appeared not to co-localize with the mito-
chondria (Figure 2B). Furthermore, when cultures were
treated with resveratrol and were separated into cell frac-
tions after 24 h, Bax protein accumulated in the high
membrane fractions enriched for mitochondria, again re-
gardless of p53-status (Figure 2C). Finally, when we stud-
ied the response to 100 M resveratrol of human HT29
colon carcinoma cells expressing the dysfunctional p53-
273H mutant, HT29 like HCT116 cells showed co-locali-
zation of Bax with mitochondria and underwent apoptot-
ic cell death upon drug treatment (data not shown),
demonstrating that this effect is not limited to one cell
line and is indeed wild-type p53 independent. Together,
these results demonstrate that active cellular Bax in colon
cancer cells co-localizes with the mitochondria in re-
sponse to resveratrol exposure, independently of the p53
tumor suppressor.
Active Bax located at the mitochondria can mediate apop-
tosis [26], and we have recently reported that resveratrol
can indeed trigger the mitochondrion form of death in
HCT116 cells [14]. Mitochondria-mediated apoptosis is
often, though not always, associated with the collapse of
the mitochondrial transmembrane potential m as the
result of leakiness of the inner mitochondrial membrane
[26]. To study whether the translocation of Bax correlates
with m changes, exponentially growing cultures of bax-
positive and bax-negative cells were treated with 100 M
resveratrol or mock-treated for various times and were
then incubated with the J aggregate-forming lipophilic
cation JC-1, which as a monomer emits green fluorescence
and in a reaction driven by m assembles into a red flu-
orescence-emitting dimer. In accord with the sensitivity of
HCT116 cells to resveratrol-induced apoptosis, and paral-
leling the co-localization of Bax to the mitochondria,
m rapidly dissipated, as indicated by the incremental
increase in JC-1 green fluorescence and the lack of a corre-
sponding increase in red fluoresence (Figure 3A). Remark-
ably, although stable for the first eight hours of drug
Figure 1
Expression of Bax and Bcl-XL, and apoptosis in human
HCT116 colon carcinoma cells treated with low doses of
resveratrol. Panel A: Total protein extracts (15 g) of
HCT116 cultures treated with 40 M resveratrol or only
DMSO (the solvent) were prepared at different times and
analyzed by immunoblotting, employing the anti-Bax N20
(1:500) and anti-Bcl-XL antibodies (1:200). Note that at this
low drug concentration, neither the level of Bax nor of Bcl-
XL changed significantly. Panel B: FACS analyses on exponen-
tially growing HCT116 cultures either mock-treated or
treated with low doses of resveratrol for 48 h exhibited sig-
nificant apoptosis in the drug-treated cultures. Error bars
depict standard deviations of the means of five experiments.
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eventually also collapsed, indicating that a Bax-independ-
ent, mitochondria-mediated death with delayed kinetics
can be triggered in HCT116 cells by resveratrol. To study
this further, Western blot analyses with antibodies direct-
ed against caspases 3 and 9 were performed. Mitochon-
dria-mediated apoptosis involves the cleavage of pro-
caspase 9 into the 36 kDa active caspase 9, which then
cleaves and thereby activates pro-caspase 3. Resveratrol
treatment (100 M) resulted in the increase of active cas-
pase 9 levels, and concomitantly, in the cleavage of pro-
caspase 3, regardless of Bax-status (Figure 3B), supporting
the suggestion that resvertrol can provoke both Bax-de-
pendent and -independent, mitochondria- and caspase-
mediated forms of apoptosis in HCT116 cells. As reported
before [14], we failed to establish a role of caspase 8 in the
resveratrol-provoked cell death, as neither caspase 8 acti-
vation in Western blot analyses nor inhibitory effects of
the caspase 8 inhibitor IETH-CHO could be observed.
We next asked how the survival of HCT116 and HCT116
bax -/- cultures is affected by resveratrol. When cells were
incubated for 48 h in the presence of increasing concen-
trations of resveratrol and subsequently FACS-scanned for
cell size and DNA content, a dose-dependent induction of
apoptosis was observed in both cultures (Figure 4A). In
Figure 2
Subcellular localization of Bax in drug-treated HCT116 cells and the p53-/- derivatives. Panel A: HCT116 and HCT116 p53-/-
cultures were treated with 100 M resveratrol (+) or mock-treated (-) and, after 24 h, stained with the mitochondria-specific
dye Mitotracker Red (MT-red) and anti-Bax N-20 antibody (1:100). Note the punctuate, cytoplasmic stain with perinuclear
concentration produced by the anti-Bax antibody in cells exposed to the drug, resembling the pattern produced by MT-red.
Panel B: Confocal microscopy of HCT116 cells treated with resveratrol for 24 h confirmed the co-localization of part of the
Bax-produced fluorescence with the MT-red fluorescence. Panel C: Immunoblot analysis on 15 g of total protein from the
high membrane (mitochondrial) fraction of cells mock-treated (-) or drug-treated (+) for 24 h. Staining with Bax and cyto-
chrome b (control) antibody (1:500) revealed the increase in Bax levels in the mitochondria fraction of resveratrol-treated
cells. The co-localization of Bax with the mitochondria was not dependent on the presence of p53.
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proximately 25 % at 20 M resveratrol and plateaued
thereafter. Although the bax-deficient cultures showed a
similar dose-dependence of apoptosis, the rate of cell
death was significantly lower. A time course over 96 h
confirmed that resveratrol at 100 M can provoke apopto-
sis in both cell lines, but much less efficiently in the bax -
/- cells (Figure 4B), documenting that resveratrol-induced
apoptosis in HCT116 cells is in part, but not entirely, de-
pendent on Bax.
To assess whether the difference in FACS analysis in the
apoptosis sensitivity between bax +/+ and bax -/- cells is
meaningful, standard colony formation assays were per-
formed. In a first set of tests, it was revealed that a short
initial exposure of the cultures to 100 M resveratrol for
up to 6 h and removal of the drug thereafter, had no del-
eterious effect on colony formation (data not shown).
This contrasted with the effects of damaging drugs such as
adriamycin (0.34 M) or 5-fluorouracil (375 M), which
inhibited colony formation under these conditions, and
suggested that resveratrol acts primarily through the re-
versible inhibition of cellular factors. In the further study,
Figure 3
Mitochondrial membrane potential changes and caspase acti-
vation. Panel A: Quotient of JC-1 red/green fluorescence as
an indicator for the membrane potential m in HCT116
cells and the bax-/- derivatives at different times after expo-
sure to 100 M resveratrol. Note that the absence of Bax
delays but fails to completely inhibit membrane potential col-
lapse. Standard deviations were derived from 4 experiments.
Panel B: Detection of cleaved (active) caspases (casp) 9 and 3
in total protein extracts from parental and bax-deficient cells
exposed to resveratrol. The anti-caspase antibodies were
used at a dilution of 1:200. Staining with anti--actin is to
show equal protein loading.
casp 9   (36 kDa)
casp 3   (20 kDa)
β-actin (45 kDa)
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Figure 4
Effect of resveratrol on the survival of the parental HCT116
cells and the bax -/- derivatives in culture. Panel A: Treat-
ment of exponentially growing cultures with different doses
of resveratrol for 48 h and quantitation of the numbers of
cells with a sub-2n-DNA content by flow-cytometry revealed
a dose-dependent increase of apoptosis in both cell lines and
a much stronger apoptotic response in the cells expressing
Bax, especially at low drug doses. Panel B: Time course of
apoptosis in exponentially growing cultures either mock-
treated or treated with 100 M resveratrol, documenting
the time-dependence of cell death induction. Note the
reduced basal level of apoptosis in the bax -/- cultures. Error
bars denote standard deviations of the means of four experi-
ments.
A
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ration of the assay. When equal numbers of live bax +/+
and bax -/- cells were seeded and mock-treated, bax -/- cells
produced more colonies (Figure 5, left figure), consistent
with the much lower basal level of cell death in these cul-
tures (see Figure 4). To be able to compare the effect of res-
veratrol on colony formation in bax +/+ and -/- cultures,
we therefore seeded numbers of live cells that gave rise to
similar colony numbers and incubated all cultures for ten
days in the presence of different concentrations of resver-
atrol. The drug decreased the numbers of colonies, and at
the highest resveratrol concentration (100 M), no colo-
nies formed, regardless of Bax-status (Figure 5). At lower
drug concentration (20 M) however, more colonies
formed consistently in the bax -/- cultures when compared
with the bax +/+ cultures (62 +15 vs. 24 +11; average + SD
from 10 flasks each), and the colonies were generally larg-
er. We interpret this to reflect the lack of inhibition of col-
ony formation by the Bax-dependent form of apoptosis in
the bax -/- cultures. In summary, our data thus show that
resveratrol at concentrations present in some foods can in-
duce in HCT116 cells i) Bax-dependent, mitochondria-
mediated apoptosis, regardless of p53-status and involv-
ing Bax co-localization with mitochondria, and ii) Bax-in-
dependent, mitochondria-mediated death. Both forms of
apoptosis may independently limit the ability of the cells
to produce colonies.
Discussion
Resveratrol has been documented to cause apoptosis in a
large number of tumor cell lines in vitro[8,14,19,22,33], in
a rat model of azoxymethane induced colon carcinogene-
sis [10], and in a mouse model of familial adenomatous
polyposis [34]. The effects of the drug on cell survival are
mediated through the activation of downstream effectors
such as caspase 3 via two major initiator pathways, the
death receptor and the mitochondrial pathway. Although
the Fas death receptor pathway has been implicated in
some forms of resveratrol-induced apoptosis [22,35],
many solid tumors seem to be affected exclusively
through the mitochondrial pathway [14,23], which inti-
mately involves the Bcl-2 protein family members of cell
survival regulators including the anti-apoptotic Bcl-2 and
Bcl-XL, and the pro-apoptotic BH-123 protein Bax [26].
Recent work has shown that Bax can be an important me-
diator of anticancer drug-induced cell death. For example,
nonsteroidal anti-inflammatory drugs (NSAIDs) cause
Bax-dependent apoptosis in human HCT116 colon carci-
noma cells [31]. In this system, the NSAID-provoked cell
death was associated with a downregulation of Bax-antag-
Figure 5
Representative colony formation assay with HCT116 and HCT116 bax -/- cells. When 1.5  103 live cells, counted in a CASY
cell counter, were seeded into 25 cm2 tissue culture flasks and were incubated for 10 days in the absence of drug, bax -/- cells
produced more colonies (left figure), indicating the survival advantage per se of bax-deficiency. Right figure: 7.5  103 live
HCT116 cells and 1.5  103 bax -/- cells were seeded into flasks and exposed to the solvent DMSO (mock) or resveratrol dis-
solved in DMSO, 24 h later. Colonies were stained with crystal violet.Page 7 of 9
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duced in response to drugs, including resveratrol [10,14].
We have shown in the present paper that a further Bax-de-
pendent mechanism of resveratrol-induced apoptosis
may be active – aside from alterations of the Bax:Bcl-XL or
Bax:Bcl-2 ratios by Bax overproduction or antagonist
downregulation: the subcellular redistribution of present
Bax protein. Since Bax expression was stimulated only at
high resveratrol concentrations while Bax translocation
and mitochondria-mediated cell death were observed also
at low concentrations, we asked what relevance Bax might
have for the chemopreventive activity of the compound.
Our results show that the lack of Bax in HCT116 colon
carcinoma cells attenuates but fails to completely inhibit
the resveratrol-induced mitochondrial form of apoptosis.
This finding is in accord with a recent report showing that
stable overexpression of Bax-antagonist Bcl-2 in U937
cells reduces, but does not prevent, resveratrol-provoked
death [36]. Along the same line, HCT116 bax -/- cells ex-
hibited a reduced sensitivity to apoptosis induction by the
anticancer drug 5-FU, but were not completely resistant
like they were in response to the NSAID sulindac [31].
One function of Bax and the related BH-123 protein Bak
is the induction of mitochondrial outer membrane per-
meability, which eventually results in the activation of ap-
optosis-executing caspases. Cells from mice deficient for
both Bax and Bak, but not cells deficient for one or the
other only, are almost completely resistant to mitochon-
dria-mediated apoptosis [37], suggesting that these pro-
teins have redundant functions in this pathway. Bak is
robustly expressed in HCT116 cells, and recent work has
shown that bax-deficient HCT116 cells are more sensitive
to apoptosis-provoking drugs such as ceramide than other
bax-deficient cells [38]. Whether Bak complements the
lack of Bax in HCT116 bax -/- cells treated with resveratrol
remains to be seen; however, recent observations with iso-
lated rat mitochondria indicate that the drug is also able
to contribute directly to the opening of the mitochondrial
permeability transition pore complex and thereby induce
the collapse of m without involving the Bax/Bak pro-
teins [23]. Combined, the available data thus indicate that
the chemopreventive agent resveratrol can affect the sur-
vival of tumor cells through several different pathways.
Most colorectal tumor cell lines apparently show decreas-
es in the ratio of the pro-apoptotic Bax and the anti-apop-
totic Bcl-XL, and recent observations suggest that
mutational inactivation of the bax gene may be frequent
in the HNPCC-predisposition to colorectal cancer and
may render these cancers resistant to important cancer
chemopreventives such as the NSAIDs [31]. The natural
plant polyphenol resveratrol, in contrast, can trigger sev-
eral different mitochondrial apoptosis pathways, and has
actually been demonstrated to prevent the formation of
colon tumors and reduce the formation of small intestinal
tumors by 70% in a mouse model of familial adenoma-
tous polyposis [34]. One might therefore consider resver-
atrol or derivatives of it, possibly in combination with
other drugs, as a chemopreventive approach to the man-
agement of patients with hereditary predispositions to
colorectal cancer.
Conclusions
Low to moderate doses of the natural cancer chemopre-
ventive ingredient of some foods, resveratrol, induce mi-
tochondrial apoptosis but fail to stimulate Bax expression
or alter the Bax:Bcl-XL ratio in human HCT116 colon car-
cinoma cells. Instead, the compound induces co-localiza-
tion of active Bax protein with the mitochondria. HCT116
cells with both bax alleles inactivated undergo mitochon-
drial apoptosis in response to resveratrol less efficiently
than the parental cells, yet cell death through the mito-
chondrial pathway is not completely inhibited. Thus, res-
veratrol can activate Bax-dependent and -independent
forms of mitochondrial apoptosis. Both forms can inde-
pendently limit the formation of colonies.
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